I
Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
NASDAQ:IMRX
Price:
1.6185 USD
1.16%
Market Closed
Updated:
May 15, 2024
Net Margin
Immuneering Corp
Immuneering Corp
0%
Current
-18 694%
Average
-8.2%
Industry
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=0%
Net Income
/
-53.5m
Revenue
0
Net Margin Across Competitors
| Country | US |
| Market Cap | 47.4m USD |
| Net Margin | N/A |
| Country | US |
| Market Cap | 289.1B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 171.1B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 112.7B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 107.8B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 136.7B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 83.7B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 49.3B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 34.2B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 39.6T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Immuneering Corp.
See Also
Discover More
What is Net Margin?
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=0%
Net Income
/
-53.5m
Revenue
0
What is the Net Margin of Immuneering Corp?
Based on Immuneering Corp's most recent financial statements, the company has Net Margin of 0%.
You don't have any saved screeners yet
